We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » OHIO FIRM CITED FOR DRUG COMPOUNDING ACTIVITIES
OHIO FIRM CITED FOR DRUG COMPOUNDING ACTIVITIES
August 9, 2004
The FDA recently issued a warning letter to Ohio-based drug manufacturer Gentere for allegedly compounding nonsanctioned copies of commercially available drugs.